ADIPOQ and eosinophilia-myalgia syndrome: In recent years, an increasing number of studies have investigated the role of adiponectin in many diseases processes, and there is growing evidence of its involvement in the regulation of apoptosis, inflammation, angiogenesis, and fibrosis (Bråkenhielm et al., 2004; Fang and Judd, 2018), and adiponectin may be associated with estrogen-related diseases (Rizzo et al., 2020; Tsankof and Tziomalos, 2022), all of which contribute to the pathogenesis of EMs.